JPH0152368B2 - - Google Patents

Info

Publication number
JPH0152368B2
JPH0152368B2 JP60140084A JP14008485A JPH0152368B2 JP H0152368 B2 JPH0152368 B2 JP H0152368B2 JP 60140084 A JP60140084 A JP 60140084A JP 14008485 A JP14008485 A JP 14008485A JP H0152368 B2 JPH0152368 B2 JP H0152368B2
Authority
JP
Japan
Prior art keywords
group
diazatetracyclo
reaction
oxa
formyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP60140084A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6110590A (ja
Inventor
Masanobu Kosaka
Hiroshi Terano
Tadaaki Komori
Morita Iwami
Michio Yamashita
Shinji Hashimoto
Itsuro Uchida
Shigehiro Takase
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS6110590A publication Critical patent/JPS6110590A/ja
Publication of JPH0152368B2 publication Critical patent/JPH0152368B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP60140084A 1984-06-25 1985-06-25 ジアザテトラシクロ化合物を含有する抗腫瘍剤 Granted JPS6110590A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8416141 1984-06-25
GB848416141A GB8416141D0 (en) 1984-06-25 1984-06-25 Fr-900482 substance
GB8510378 1985-04-24

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP63325492A Division JPH078872B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-06-25 1988-12-22

Publications (2)

Publication Number Publication Date
JPS6110590A JPS6110590A (ja) 1986-01-18
JPH0152368B2 true JPH0152368B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-11-08

Family

ID=10562947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60140084A Granted JPS6110590A (ja) 1984-06-25 1985-06-25 ジアザテトラシクロ化合物を含有する抗腫瘍剤

Country Status (4)

Country Link
US (1) US4861774A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6110590A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB8416141D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA854469B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB974168A (en) * 1961-06-26 1964-11-04 Ici Ltd Manufacture of 2-ª‰-methoxyethylpyridine

Also Published As

Publication number Publication date
JPS6110590A (ja) 1986-01-18
GB8416141D0 (en) 1984-08-01
US4861774A (en) 1989-08-29
ZA854469B (en) 1986-02-26

Similar Documents

Publication Publication Date Title
KR930010705B1 (ko) Fr-900520 물질의 제조방법
HU211514A9 (en) Fr 901228 substance and preparation thereof
KR940000759B1 (ko) 신규 글리코펩티드계 항생물질의 제조방법
KR900004066B1 (ko) 생물학적으로 활성인 ws 6049의 제조방법
KR960013432B1 (ko) 항균제 fr109615 및 이의 제조방법
WO2001012643A1 (fr) Caprazamycines antibiotiques et leur procede de production
KR920009527B1 (ko) 신규의 테트라사이클로 화합물의 제조방법
JPS6365679B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US5260447A (en) Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use
JP4054576B2 (ja) 抗生物質トリプロペプチン類およびその製造法
JPH0152368B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US4346075A (en) Antibiotic DC-11 and process for production thereof
EP0365329B1 (en) Antibiotics active against anaerobic bacteria, their production and use, and strains of enterobacter producing the same
JPH0676425B2 (ja) Ws―9326a、ws―9326bおよびそれらの誘導体
US4393056A (en) Antibiotics tetronolide compounds and process for production thereof
JP2002518057A (ja) ムンバイスタチン、その製造法およびその医薬としての使用
KR0130473B1 (ko) 새로운 항생물질, 베나노마이신 a와 b 및 덱실오실베나노마이신 b와 이들의 제조 방법과 용도
JP2862986B2 (ja) ジテルペン化合物およびその製造法
US4939241A (en) Amino acid derivatives of antitumor activity
JP2748048B2 (ja) It−62−b物質及びこれを含有する医薬組成物
JPH05155888A (ja) 新規な抗生物質およびそれらの製造
JP3055973B2 (ja) 抗生物質アルデカルマイシンとその製造法、並びにその誘導体とその製造法
JPH0558440B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH10114777A (ja) 抗生物質スピロキシマイシンとその製造法
JP3773310B2 (ja) Uck14化合物